Gemcitabine and docetaxel in advanced soft tissue sarcomas
Not Applicable
- Conditions
- advanced soft tissue sarcomas
- Registration Number
- JPRN-UMIN000007360
- Lead Sponsor
- agoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
*severe pleural effusion/cardiac effusion/ascites fluid *serious cardiac disorder *cerebrovascular disease *uncontrolled diabetes *uncontrolled hypertension *symptomatic brain metastasis *active infection *pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor response was classified by Response Evaluation Criteria in Solid tumor (RECIST) guideline.
- Secondary Outcome Measures
Name Time Method median survival period adverse event